These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 11723862)

  • 21. [Electrophysiological assessment of reflex pathways involved in spasticity].
    Lefaucheur JP
    Neurochirurgie; 2003 May; 49(2-3 Pt 2):205-14. PubMed ID: 12746695
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Repetitive transcranial magnetic stimulation of the motor cortex ameliorates spasticity in multiple sclerosis.
    Centonze D; Koch G; Versace V; Mori F; Rossi S; Brusa L; Grossi K; Torelli F; Prosperetti C; Cervellino A; Marfia GA; Stanzione P; Marciani MG; Boffa L; Bernardi G
    Neurology; 2007 Mar; 68(13):1045-50. PubMed ID: 17389310
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantifying spasticity in a clinical setting.
    Norris JA; Cabrera MN; Smith TL; Reeves SH; Koman LA
    Biomed Sci Instrum; 2007; 43():284-9. PubMed ID: 17487095
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathophysiology of spastic paresis. II: Emergence of muscle overactivity.
    Gracies JM
    Muscle Nerve; 2005 May; 31(5):552-71. PubMed ID: 15714511
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment: botulinum neurotoxin for the treatment of spasticity (an evidence-based review).
    Simpson DM; Gracies JM; Graham K; Hallett M; Miyasaki J; Naumann M; Russman B; Simpson L; So Y
    Neurology; 2009 Sep; 73(9):736-7; author reply 737-8. PubMed ID: 19728407
    [No Abstract]   [Full Text] [Related]  

  • 26. Change of stretch reflex threshold in spasticity: effect of botulinum toxin injections.
    Stampacchia G; Bradaschia E; Rossi B
    Arch Ital Biol; 2004 May; 142(3):265-73. PubMed ID: 15260380
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduction of spastic tone increase induced by peripheral repetitive magnetic stimulation is frequency-independent.
    Krause P; Straube A
    NeuroRehabilitation; 2005; 20(1):63-5. PubMed ID: 15798358
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Basic principles and therapy of spasticity].
    Dietz V
    Ther Umsch; 2000 Nov; 57(11):684-9. PubMed ID: 11143182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural and mechanical alterations in spastic skeletal muscle.
    Foran JR; Steinman S; Barash I; Chambers HG; Lieber RL
    Dev Med Child Neurol; 2005 Oct; 47(10):713-7. PubMed ID: 16174321
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The spinal pathophysiology of spasticity--from a basic science point of view.
    Nielsen JB; Crone C; Hultborn H
    Acta Physiol (Oxf); 2007 Feb; 189(2):171-80. PubMed ID: 17250567
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Botulinum neurotoxin intramuscular chemodenervation. Role in the management of spastic hypertonia and related motor disorders.
    Yablon SA
    Phys Med Rehabil Clin N Am; 2001 Nov; 12(4):833-74, vii-viii. PubMed ID: 11723867
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Principles of pharmaceutical management of spastic hypertonia.
    Elovic E
    Phys Med Rehabil Clin N Am; 2001 Nov; 12(4):793-816, vii. PubMed ID: 11727721
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathophysiology of spastic paresis. I: Paresis and soft tissue changes.
    Gracies JM
    Muscle Nerve; 2005 May; 31(5):535-51. PubMed ID: 15714510
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurophysiological and kinesiological aspects of spastic gait: the need for a functional approach.
    Mayer M
    Funct Neurol; 2002; 17(1):11-7. PubMed ID: 12086107
    [No Abstract]   [Full Text] [Related]  

  • 35. Epimuscular myofascial force transmission between antagonistic and synergistic muscles can explain movement limitation in spastic paresis.
    Huijing PA
    J Electromyogr Kinesiol; 2007 Dec; 17(6):708-24. PubMed ID: 17383897
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Botulinum toxin in post-stroke patients: stiffness modifications and clinical implications.
    Miscio G; Del Conte C; Pianca D; Colombo R; Panizza M; Schieppati M; Pisano F
    J Neurol; 2004 Feb; 251(2):189-96. PubMed ID: 14991354
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Suprasegmental effects of selective posterior rhizotomy].
    Horínek D; Tichý M; Cerný R; Vlková J
    Cas Lek Cesk; 2004; 143(8):512-6. PubMed ID: 15446453
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proprioception and locomotor disorders.
    Dietz V
    Nat Rev Neurosci; 2002 Oct; 3(10):781-90. PubMed ID: 12360322
    [No Abstract]   [Full Text] [Related]  

  • 39. Physical modalities other than stretch in spastic hypertonia.
    Gracies JM
    Phys Med Rehabil Clin N Am; 2001 Nov; 12(4):769-92, vi. PubMed ID: 11723865
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inferior mechanical properties of spastic muscle bundles due to hypertrophic but compromised extracellular matrix material.
    Lieber RL; Runesson E; Einarsson F; Fridén J
    Muscle Nerve; 2003 Oct; 28(4):464-71. PubMed ID: 14506719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.